- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 5: Clinical Pathways - A Shared Decision-Making Tool?
Have clinical pathways in oncology developed enough for providers and patients to use them as a shared decision-making tool? Panelists provide insight.
The panel then discussed their view on clinical pathways as a shared decision-making tool.
Blaise Polite, MD, MPP, said that they could be used in that capacity, “but they are not typically designed that well to open up in front of the patient.” He believes there are other, much better, tools for the process.
Michael Fisch, MD, MPH, agreed that clinical pathways are not intended to be a shared decision-making tool. While patients and their physicians make clinical decisions, pathways do not lead the discussion, he added.
Kathy Lokay concurred, saying that discussions on using pathways as a tool would really depend on the interest the patient might have in the process.
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
